GALT icon

Galectin Therapeutics

75 hedge funds and large institutions have $22.7M invested in Galectin Therapeutics in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$226K
Puts
$266K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.69M
2
$4.19M
3
$2.65M
4
$2.26M
5
$1.4M
6
$1.33M
7
$913K
8
$666K
9
$401K
10
$384K
11
$218K
12
$216K
13
$169K
14
$154K
15
$142K
16
$122K
17
$103K
18
$100K
19
$99K
20
$89K
21
$75K
22
$68K
23
$67K
24
$67K
25
$57K